Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Richard Neal Mitchell, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Richard Mitchell and Peter Libby.
Connection Strength

1.974
  1. Vascular remodeling in transplant vasculopathy. Circ Res. 2007 Apr 13; 100(7):967-78.
    View in: PubMed
    Score: 0.363
  2. CC chemokine receptor-1 activates intimal smooth muscle-like cells in graft arterial disease. Circulation. 2009 Nov 03; 120(18):1800-13.
    View in: PubMed
    Score: 0.108
  3. Adiponectin inhibits allograft rejection in murine cardiac transplantation. Transplantation. 2009 Oct 15; 88(7):879-83.
    View in: PubMed
    Score: 0.108
  4. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2006 May; 26(5):987-94.
    View in: PubMed
    Score: 0.084
  5. Characterization of smooth muscle-like cells in circulating human peripheral blood. Atherosclerosis. 2006 Aug; 187(2):351-62.
    View in: PubMed
    Score: 0.082
  6. Local cytokine environments drive aneurysm formation in allografted aortas. Trends Cardiovasc Med. 2005 May; 15(4):142-8.
    View in: PubMed
    Score: 0.079
  7. Wild-type but not interferon-gamma-deficient T cells induce graft arterial disease in the absence of B cells. Cardiovasc Res. 2004 Aug 01; 63(2):347-56.
    View in: PubMed
    Score: 0.075
  8. Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. J Clin Invest. 2004 Jul; 114(2):300-8.
    View in: PubMed
    Score: 0.075
  9. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins. Circulation. 2003 Oct 28; 108(17):2113-20.
    View in: PubMed
    Score: 0.071
  10. Tumor necrosis factor receptor -1 and -2 double deficiency reduces graft arterial disease in murine cardiac allografts. Am J Transplant. 2003 Aug; 3(8):968-76.
    View in: PubMed
    Score: 0.070
  11. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J Immunol. 2002 Aug 01; 169(3):1556-60.
    View in: PubMed
    Score: 0.066
  12. Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non-immunosuppressed hosts. Am J Pathol. 2002 Mar; 160(3):1077-87.
    View in: PubMed
    Score: 0.064
  13. Coronavirus Disease 2019 (COVID-19) Coronary Vascular Thrombosis: Correlation with Neutrophil but Not Endothelial Activation. Am J Pathol. 2021 Sep 29.
    View in: PubMed
    Score: 0.062
  14. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy. Nat Med. 2001 Jun; 7(6):738-41.
    View in: PubMed
    Score: 0.060
  15. Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allografts. Circulation. 2001 Jan 30; 103(4):525-31.
    View in: PubMed
    Score: 0.059
  16. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol. 2000 Sep 15; 165(6):3506-18.
    View in: PubMed
    Score: 0.058
  17. Association of B7-1 co-stimulation with the development of graft arterial disease. Studies using mice lacking B7-1, B7-2, or B7-1/B7-2. Am J Pathol. 2000 Aug; 157(2):473-84.
    View in: PubMed
    Score: 0.057
  18. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol. 1999 Dec; 155(6):1929-39.
    View in: PubMed
    Score: 0.054
  19. Deficiencies of IL-4 or TNF-alpha receptor-1 do not diminish graft arteriosclerosis in cardiac allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):152.
    View in: PubMed
    Score: 0.051
  20. Interferon-gamma-secreting T-cell populations in rejecting murine cardiac allografts: assessment by flow cytometry. Am J Pathol. 1998 Nov; 153(5):1383-92.
    View in: PubMed
    Score: 0.051
  21. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells. Am J Pathol. 1998 Jul; 153(1):69-79.
    View in: PubMed
    Score: 0.049
  22. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. Am J Pathol. 1998 May; 152(5):1187-97.
    View in: PubMed
    Score: 0.049
  23. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest. 1997 Aug 01; 100(3):550-7.
    View in: PubMed
    Score: 0.046
  24. Macrophages Facilitate Electrical Conduction in the Heart. Cell. 2017 04 20; 169(3):510-522.e20.
    View in: PubMed
    Score: 0.045
  25. Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection. Circulation. 2011 Dec 20; 124(25):2920-32.
    View in: PubMed
    Score: 0.031
  26. Leukocyte integrin Mac-1 promotes acute cardiac allograft rejection. Circulation. 2008 Apr 15; 117(15):1997-2008.
    View in: PubMed
    Score: 0.024
  27. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation. Circ Res. 2004 Mar 19; 94(5):601-8.
    View in: PubMed
    Score: 0.018
  28. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. J Immunol. 1999 Oct 01; 163(7):3753-7.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.